Implantable Device Targets Pancreatic Cancer

A research team from Mass General and MIT has designed a tiny, adjustable implant that could be used to deliver chemotherapy drugs directly into pancreatic cancers, instead of requiring the drugs to travel through the entire circulatory system to reach the pancreas.

In laboratory models, delivering treatment directly to the source proved to be 12 times more effective than intravenous delivery, the common treatment for pancreatic


Leave a Reply